MOR106

a new antibody in development
for atopic dermatitis

MOR208

an investigational antibody
for blood cancer

Anetumab
ravtansine

A drug candidate for mesothelioma

Guselkumab

An antibody developed by
Janssen Research & Development, LLC
based on MorphoSys’s HuCAL
antibody library

Annual Report 2016

Engineering the Medicines
of Tomorrow

MOR106
MOR208
ANETUMAB RAVTANSINE
GUSELKUMAB
arrow-topCreated with sketchtool.